These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 24834833)
1. Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation. Len O; Montejo M; Cervera C; Fariñas MC; Sabé N; Ramos A; Cordero E; Torre-Cisneros J; Martín-Dávila P; Azanza JR; Pahissa A; Gavaldà J; Transpl Infect Dis; 2014 Aug; 16(4):532-8. PubMed ID: 24834833 [TBL] [Abstract][Full Text] [Related]
2. Daptomycin in solid organ transplantation: consideration of dosage adjustments in renal impairment. Pea F Transpl Infect Dis; 2014 Oct; 16(5):868-9. PubMed ID: 25040943 [No Abstract] [Full Text] [Related]
3. [Daptomycin in Gram-positive bacterial infections in oncohematological patients and transplant recipients]. Carratalà J; Len O; de la Torre-Cisneros J Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():43-9. PubMed ID: 22541975 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci. Cervera C; Castañeda X; Pericas JM; Del Río A; de la Maria CG; Mestres C; Falces C; Marco F; Moreno A; Miró JM Int J Antimicrob Agents; 2011 Nov; 38(5):365-70. PubMed ID: 21420835 [TBL] [Abstract][Full Text] [Related]
5. Management of gram-positive coccal bacteremia and hemodialysis. Fitzgibbons LN; Puls DL; Mackay K; Forrest GN Am J Kidney Dis; 2011 Apr; 57(4):624-40. PubMed ID: 21333430 [TBL] [Abstract][Full Text] [Related]
8. [Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient]. Alvarez-Lerma F; Gracia-Arnillas MP Med Clin (Barc); 2010 Dec; 135 Suppl 3():29-35. PubMed ID: 21477702 [TBL] [Abstract][Full Text] [Related]
9. Daptomycin in the treatment of bacteremia. Sakoulas G; Golan Y; Lamp KC; Friedrich LV; Russo R Am J Med; 2007 Oct; 120(10 Suppl 1):S21-7. PubMed ID: 17904947 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU]. Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544 [TBL] [Abstract][Full Text] [Related]
11. [The efficacy and safety of daptomycin for the treatment of Gram-positive bacterial infections in Chinese population]. Zhang L; Li J; Wan X; Shen J; Liu H; Gao H; Liu Z; Wang A Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):496-500. PubMed ID: 26359009 [TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin. Beiras-Fernandez A; Kur F; Kiefer S; Sodian R; Schmoeckel M; Weis M; Reichart B; Weis F Transplant Proc; 2009; 41(6):2589-91. PubMed ID: 19715980 [TBL] [Abstract][Full Text] [Related]
13. Daptomycin experience in patients with human immunodeficiency virus and resistant gram-positive infections. Slim J; Jimenez H; Culshaw D; Patel H; Lamp KC J Int Assoc Provid AIDS Care; 2015; 14(3):202-6. PubMed ID: 25320146 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis. Kullar R; McClellan I; Geriak M; Sakoulas G Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897 [TBL] [Abstract][Full Text] [Related]
15. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections. Kanafani ZA; Corey GR Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752 [TBL] [Abstract][Full Text] [Related]
17. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy. Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384 [TBL] [Abstract][Full Text] [Related]
18. [Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin - first experiences from the EU-CORE registry study (European Cubicin® Outcomes Registry and Experience)]. Lübbert C; Wilhelms D; Worlitzsch D; Ettrich TJ; Behl S; Seufferlein T Z Gastroenterol; 2012 Apr; 50(4):373-81. PubMed ID: 22430297 [TBL] [Abstract][Full Text] [Related]
19. [Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure]. Sarriá Cepeda C Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():38-42. PubMed ID: 22541974 [TBL] [Abstract][Full Text] [Related]